Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (8-(7-chloro(1,8)naphthyridin-2-yl)-7-oxo-2,5-dithia-8-azabicyclo(4.3.0)non-10-en-9-yl) 4-methylpiperazine-1-carboxylate
2. 6-(7-chloro-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-7-oxo-5h-(1,4)dithiino(2,3-c)pyrrol-5-yl-4-methylpiperazine-1-carboxylate
3. Rp 31264
4. Rp-3124
5. Rp-31264
1. Suril
2. 53813-83-5
3. Celexane
4. Rp 31264
5. Rp-31264
6. Lnc9g689vr
7. Celexane; Rp 31264; Suriclone
8. Suriclonum
9. Suriclon
10. Suriclona
11. Suriclon [inn-french]
12. Suriclonum [inn-latin]
13. Suriclona [inn-spanish]
14. Einecs 258-794-1
15. 6-(7-chloro-1,8-naphthyridin-2-yl)-7-oxo-2,3,6,7-tetrahydro-5h-[1,4]dithiino[2,3-c]pyrrol-5-yl 4-methylpiperazine-1-carboxylate
16. Suriclone [inn:ban]
17. Unii-lnc9g689vr
18. Suriclone [inn]
19. Suriclone [mi]
20. Suriclone [mart.]
21. (r,s)-6-(7-chlor-1,8-naphthyridin-2-yl)-3,5,6,7-tetrahydro-5-oxo-2h-(1,4)dithixino(2,3-c)pyrrol-7-yl-4-methyl-1-piperazinylcarboxylat
22. [6-(7-chloro-1,8-naphthyridin-2-yl)-5-oxo-3,7-dihydro-2h-[1,4]dithiino[2,3-c]pyrrol-7-yl] 4-methylpiperazine-1-carboxylate
23. Schembl114688
24. Chembl2105561
25. Dtxsid20866362
26. 31264-rp
27. 4-methyl-1-piperazinecarboxylic Acid Ester With (+-)-6-(7-chloro-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-7-hydroxy-5h-p-dithiino(2,3-c)pyrrol-5-one
28. Q7646277
29. 1-piperazinecarboxylic Acid, 4-methyl-, 6-(7-chloro-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-7-oxo-5h-1,4-dithiino(2,3-c)pyrrol-5-yl Ester
Molecular Weight | 478.0 g/mol |
---|---|
Molecular Formula | C20H20ClN5O3S2 |
XLogP3 | 2.8 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 3 |
Exact Mass | 477.0696096 g/mol |
Monoisotopic Mass | 477.0696096 g/mol |
Topological Polar Surface Area | 130 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 763 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
ABOUT THIS PAGE
A Suriclone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Suriclone, including repackagers and relabelers. The FDA regulates Suriclone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Suriclone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Suriclone supplier is an individual or a company that provides Suriclone active pharmaceutical ingredient (API) or Suriclone finished formulations upon request. The Suriclone suppliers may include Suriclone API manufacturers, exporters, distributors and traders.
click here to find a list of Suriclone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Suriclone DMF (Drug Master File) is a document detailing the whole manufacturing process of Suriclone active pharmaceutical ingredient (API) in detail. Different forms of Suriclone DMFs exist exist since differing nations have different regulations, such as Suriclone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Suriclone DMF submitted to regulatory agencies in the US is known as a USDMF. Suriclone USDMF includes data on Suriclone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Suriclone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Suriclone suppliers with USDMF on PharmaCompass.
Suriclone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Suriclone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Suriclone GMP manufacturer or Suriclone GMP API supplier for your needs.
A Suriclone CoA (Certificate of Analysis) is a formal document that attests to Suriclone's compliance with Suriclone specifications and serves as a tool for batch-level quality control.
Suriclone CoA mostly includes findings from lab analyses of a specific batch. For each Suriclone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Suriclone may be tested according to a variety of international standards, such as European Pharmacopoeia (Suriclone EP), Suriclone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Suriclone USP).
LOOKING FOR A SUPPLIER?